Vaccine Irony: COVID Complicates Review, Uptake Of New RSV Vaccines

COVID vaccines saved the world and then became a liability. US FDA vaccine advisors cited COVID experience as they urge agency to slow down on approval of new RSV vaccines, due to worries of declining public vaccine confidence and coadministration complications.

person holding small, cute dog in front of "beware of dog" sign
The scientific success of COVID vaccines may not help the broader vaccine pipeline. • Source: Shutterstock

In a strange twist of irony for new vaccine developers, the success of vaccines in curtailing the COVID-19 pandemic may be more of a liability than an asset.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America